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Abstract 
Nowadays, there is a growing interest in using saliva as an alternative sample for the diagnosis, prediction and 
progression of several diseases. It has been established that some molecules found in saliva are related to oral 
inflammatory processes and systemic health status. Furthermore, it is known that saliva is crucial for the carrying 
out of different functions in the oral cavity and its role in the local modulation of inflammatory and immune res-
ponse is being thoroughly studied by the health research community. The aim of this review is to analyze the most 
important biomarkers which have been utilized in biomedicine during the last two decades in order to establish a 
correlation between certain specific salivary biomarkers and systemic inflammation. Then, we discuss the utility of 
total proteins, immunoglobulin A and alpha-amylase as biomarkers for the prognostic of local inflammation after 
oral surgery. 
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Introduction
During the last decades, salivary diagnostic approaches 
have been developed to diagnose and monitor oral di-
seases such as caries risk, microbial sepsis, inflamma-
tion and genetic pathologies like oral tumors and cysts. 
Buccal inflammatory biomarkers are biomolecules as 
proteins and derivatives which show an increase or de-
crease in buccal processes coursing with inflammation. 
These biomarkers are commonly used in biomedicine to 
confirm the level and type of inflammation present in 
oral diseases. The local concentration of these proteins 
varies depending on habits, age, sex or the place whe-
re the sample was taken from (oral mucosa or another). 
The most common fluids used in inflammation prognos-
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tic assays are: Saliva, crevicular fluid and serum. Cyto-
kines (TNF-α & IFN-γ, IL-1,4,6,8,10), IgA, α-Amylase, 
Cortisol and Total Proteins
are the most frequently used inflammatory salivary bio-
markers in the recent decades and utilized in biomedical 
prognostic (1-5). 
In the brain, cytokines are essential components of a 
signaling complex network in body inflammation. IL-1, 
IL-4, IL-6, IL-8 e IL-2 along with TNF- α and the IFN-γ 
are the most habitual cytokines used like inflammatory 
salivary biomarkers since they have become in the most 
influential molecules in the risk detection site of the pa-
tient, also for other inflammatory chain factors activa-
tion and for the proper inflammation process (6-9). In 
addition, the alpha tumor necrosis factor is a very im-
portant protein cytokine for neutrophils and other blood 
cell activation in acute inflammatory process into sepsis 
and oral diseases like periodontitis and its diagnosis (6, 
10). Furthermore, the Gamma interferon is also a pro-
tein cytokine that is secreted by T-cells to perform ma-
crophages activation in oral diseases like periodontitis in 
the inflammation process (11).
Focused on IgA, it is an immunoglobulin type protein 
like a biomarker of immunological activity which is 
presented in seromucinous fluids as the primary defen-
se against pathogens. The level of this protein increases 
significantly in case of infectious diseases, as well as 
IgG and IgM such in case of periodontitis, showing a 
positive correlation between the severity of periodontal, 
gingival damage and IgA concentrations. These concen-
trations are crucial in antibacterial, antifungal and anti-
viral process (12-17).
The alpha amylase is an enzyme of polysaccharides 
degradation which is used on the treatment and in the 
prognostic of inflammatory diseases, in actinomycetems 
infection and against some bacteria as the ones that cau-
se caries (3,18-22). The AASH, especially for its high 
concentration, has been used as a biomarker. Its con-
centration is 1080 ± 135.6 IU or 476 ± 120 mg / ml in 
adults. 
Nevertheless, all the proteins concentration is the sum 
of the levels of each protein into the oral fluids and they 
are also quite relevant and significant in inflammation 
process, in clinical analysis and in the diagnostic of 
some diseases which show a linear increase correlation 
in patients with high advanced age and caries (12,23). 
However, cortisol is an anti-inflammatory hormone that 
is used in several assays but its results present several 
variances between sex, day and type of assay and they 
are not always statistically significant (4,12,20). Others 
buccal salivary biomarkers are involved in oral fluids: 
Protein-2, Protein-3B, Chaperokines, Cystatin, Lysozi-
me-C, Lipocalin, BPI, Collagenases MMP-8, PLUNC, 
Mucins, Peroxidases, Prolin-rich Protein, Chromograni-
ne-A, LDH, Reactive Protein-C (18-20,24,25).
The advantage of using saliva as a diagnostic means is 
that their sampling is easy and non-invasive but this po-
tential has not been fully exploited, due to the lack of 
some techniques to detect components that are in less 
concentration. However, it is expected that with the 
advancement of bioinformatics, genomics and proteo-
mics, saliva becomes increasingly a study tool, due to its 
ability to reflect conditions of oral and systemic health 
(26,27).
It is obvious that after any surgery in the oral cavity, it 
appears in varying degrees postoperative swelling as 
physiological response of the organism; the preventive 
philosophy of such symptoms is based on anticipating 
to the appearance for trying to minimize them. While 
postoperative orofacial pain is a direct result of the da-
mage caused by the surgery and the body’s response to 
it, we should not forget that pain perception varies with 
each patient based on certain factors. The importance of 
the anxiety and the degree of stress of the patient in the 
postoperative pain perception, has been widely studied 
by different authors, who defined that anxiety can leng-
then the time of the intervention by inducing greater pain 
and inflammation and it can also increase the intensity of 
both postoperative symptoms possibly by reducing the 
threshold of pain tolerance (28).
Saliva concentrations of total protein, immunoglobulin 
A and alpha-amylase vary when inflammation occurs 
within infectious processes of the oral cavity. Similarly 
we seek to relate the preoperative values of those sa-
livary markers with the postoperative ones, which will 
allow us to establish a prognostic value of inflammation 
that will occur in the postoperative period. Through the 
availability of studies to increase knowledge of the sali-
vary prognostic factors related to inflammation will help 
to improve the quality of the healthcare. Furthermore, 
this study proposes innovative cooperation of two areas 
of health sciences: oral surgery and molecular biology 
(29).
Discussion
In recent years, several analytes in saliva have been 
evaluated as biomarkers for many diseases including: 
cancer (30,31), type II diabetes (32), infections (33,34), 
pulmonary (35) and cardiovascular diseases (36), among 
others. These findings allow facilitating the diagnostic 
of systemic illness because saliva is a non-invasive and 
easy-to-use sample.
Abnormal cortisol rhythms before epithelial ovarian 
cancer treatment has been associated with higher infla-
mmation in the tumor zone and decreased survival of 
patients. In this sense, nocturnal concenrations level 
has been proposed as a measure of the hypothalamic-
pituitary-adrenal (HPA) dysfunction that occurs in this 
kind of cancer and an indicator of disease severity. In 
this study, an association between ascites pro-inflamma-
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tory cytokine IL-6 and salivary cortisol was observed; 
indicating night concentration may be an efficient bio-
marker for measuring HPA function in ovarian cancer 
population (37).
Other researchers have focused on secretory proteins 
as cancer biomarkers because they are closely related 
with the malignant tumor angiogenesis, differentiation, 
invasion and metastasis process (38). Although most 
studies have been performed to identify such biomar-
kers in serum (38-40), there are some of them interes-
ted in identifying saliva secretory proteins that could be 
used as cancer biomarkers. Shiiki et al. have examined 
levels of Prostate-specific Antigen (PSA) in saliva and 
its association with serum PSA  in two groups of patients 
with prostate adenocarcinoma (PA), a low-serum PSA 
concentration group and a high-serum PSA concentra-
tion group with high risk of recurrence or metastasis. 
They concluded  that saliva PSA may be a useful PA 
biomarker in those cases in which patients have recu-
rrent or metastatic PA, as in this situation saliva PSA 
concentration is associated with blood PSA (41). In this 
same field, Streckfus et al. suggest salivary proteins as 
biomarkers for carcinoma in situ of the breast (DCIS). 
They studied saliva specimens from three groups of wo-
men (ten healthy subjects, ten patients diagnosed with 
a benign breast tumor and ten women diagnosed with 
DCIS). Their results revealed that protein-by-products 
of oncogenic expression appear in the saliva of breast 
cancer patients but not in healthy controls (42).
In the other hand, there are several antigens that are ex-
pressed in tumor cells but not in normal ones or, at least, 
not at that high concentration so these tumors associated 
antigens might act as tumor associated antigens. In this 
situation, the immune system would prepare for recog-
nizing tumor cells (43). At this point, it is reasonable to 
think that several antibodies can act as predictors in the 
diagnosis of this malignancy and, in fact, protein p53 an-
tibodies IgA and IgG have been found in the serum and 
saliva of patients who overexpressed p53 in their tumor 
tissues, demonstrating that the detection of these antibo-
dies could identify oral squamous cell carcinoma with 
p53 mutations, which occurs in 50% of cases (44,45).
In coronary heart disease, several biomarkers can be de-
tected in saliva and its levels vary from those measured 
in healthy individuals. In this sense, changes in concen-
tration of active matrix metalloproteinase (MMP)-8, 
creatinine phosphokinase, troponin I have been obser-
ved in saliva and these altered concentrations of bio-
markers correlates with serum concentration, so again 
saliva results a useful sample for diagnosing systematic 
diseases (46-48).
In Acute Myocardial Infarction (AMI), fast diagnostic is 
essential for optimal therapy to be offered because every 
minute of delay in treating AMI increases the mortali-
ty rate (49). Saliva contains thousands of biomolecules 
that are derived from the local capillary bed (50), which 
makes saliva a potential source for a rapid diagnosis of 
AMI in the emergency setting (51-53). In the research of 
specific salivary biomarkers with clinical potential for 
the assessment of AMI, C-reactive protein, sCD40L and 
CK-MB, as well as creatinine phosphokinase, TnT, and 
TnI resulted useful diabetes (32). 
As well as others systemic diseases, inflammation is a 
condition in which many studies have focused. Among 
them a small number of studies have investigated infla-
mmation markers in saliva as they are altered in respon-
se to an acute stressor. In this sense, several studies have 
proposed salivary biomarkers to identify different stress 
status. Among these, salivary levels of pro-inflammatory 
cytokines and anti-inflammatory cytokines have resulted 
to be increased in those subjects exposed to a stress si-
tuation (54-56).
In this field, Mahmood and Ibrahim, 2013, have de-
monstrated increased levels of pro-inflammatory inter-
leukin 1-beta in saliva from 24 healthy students when 
they were subject to examination stress. These results 
support those found by Usui et al., 2012, when testing 
saliva from 10 physically active participants exposed to 
a 60 minute exercise stressor. In this case, levels of IL-
1b, IL-6 and TNF-alpha were significantly higher du-
ring completion than those measured during the resting 
session. Besides, elevation in TNF-alpha and IL-2 sali-
vary levels have been detected in University professors 
120 after exposures to social-cognitive stressors (56). 
The same approach was observed when testing concen-
trations of anti-inflammatory cytokines IL-4, in saliva 
samples taken from individuals before and after stress 
conditions.
Others biomarkers have been assayed not because it is 
useful as inflammation indicators, but as direct markers 
of immune system status. This way, salivary immuno-
globulin A (sIgA) has been measured as a predictor for 
immunity variations caused by stress (57).
The immune response has been proposed as a mecha-
nism of protection, a mediator of injury, and a need for 
repairing tissues in periodontal disease. Immunoglobu-
lins have been recognized as elements in human inflamed 
gingiva. Brandtzaeg and Kraus studied the most striking 
difference between saliva samples in healthy and infla-
med gums and it was found a predominant increase in 
the number of plasma cells containing IgA using the im-
munofluorescence method (58).
Many studies have been published about the concentra-
tion of IgA in saliva but data are extremely confusing. 
The concentration of IgA in samples of whole saliva or 
mainly of the parotid (59), has been discussed in diffe-
rent investigations, linking them with oral pathological 
processes, obtaining different results due to the influen-
ce of various factors such as the maintenance in cold, sa-
liva collected at rest or after some kind of stimulation, or 
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stress to which the patient has been undergone. Several 
studies about salivary IgA concentration was analyzed in 
young patients with oral inflammation to see if there were 
significant differences between saliva samples collected 
at rest or stimulated (60). According to scientific eviden-
ce, the IgA concentrations is higher in parotid than mixed 
saliva and after stimulation, the concentration of salivary 
IgA decreases in both types of saliva (3.1 ± 2.2 mg / dl in 
mixed saliva and 6.8 ± 5 mg dl parotid salivary). 
Similarly, another study measured the concentration of 
IgA in mixed saliva and of the parotid exclusively (61) 
in individuals with gingival inflammation as a conse-
quence of an infection, obtaining in both samples a simi-
larity in the concentration of IgA. This could be due to 
prolonged activity of bacterial antigens, the stimulation 
of IgA production, the increase of absorption of combi-
ned antigen through inflamed gingiva or glandular local 
production of IgA among other factors (58).
In addition, investigation has been interested in the use of 
salivary biomarkers for detecting type-2 Diabetes. Rao 
et al., 2009, used whole saliva samples from control and 
type-2 diabetic individuals to identify such biomarkers. 
They found 65 proteins that were greater than 2-fold 
more abundant in type-2 diabetes samples compared to 
control specimens, providing a view of saliva potential 
utility in detecting and monitoring 
In recent decades, there has been considerable progress in 
the understanding of the genetic and biochemical proper-
ties of the major salivary proteins. Salivary proteins and 
glycoproteins are the major components of the biofilm, 
whose function is to keep moisture and act as a barrier to 
protect the teeth and structures around the teeth (23).
There are numerous defense proteins in saliva. Although 
some of these molecules are present in very low concen-
trations, its effects are additive and synergistic, resulting 
in an efficient molecular defense network of the oral ca-
vity. Moreover, the local concentrations of these proteins 
near mucosal surfaces (transudate mucosa), periodontal 
groove (fluid crevicular gingiva) and oral wounds and 
ulcers (transudate) can be much larger, and often rein-
forced by immune reactions and inflammatory diseases 
of the oral mucosa (62,63). Some defense proteins, such 
as salivary immunoglobulin are involved in innate and 
acquired immunity. Cationic peptides and other defense 
proteins such as lysozyme, salivary amylase, cystatins, 
mucin, peroxidases, and statherin, among others, are 
primarily responsible for innate immunity. Salivary flow 
and concentration of various inorganic and organic com-
ponents may vary by state of health, age, medication, 
etc (64).
It was observed some alterations in the biochemical 
composition of saliva in patients with oral leukoplakia 
and cancer which could be attributed to salivary gland 
dysfunction caused by alcohol and snuff due to chronic 
alcohol intake is associated with significant changes in 
the secretion the parotid saliva and its composition. The 
alcohol consumption causes a decrease in the flow of 
whole unstimulated saliva and therefore there is also a 
lower total protein content, alpha-amylase and electro-
lytes (63).
The human salivary α-amylase (AASH) is the saliva pro-
tein found in greater concentration and has enzymatic ac-
tivity, which catalyzes the links α-1, 4-glycosidic of star-
ches and carbohydrates. Also it plays an important role 
in the colonization and metabolism of the bacteria that 
lead to plaque formation. In solution, this protein binds 
with high affinity to a select group of oral streptococci, 
which can assist in debugging or bacterial cleaning the 
oral cavity (63). It is produced locally in salivary gland 
and its secretion is controlled by the autonomic nervous 
system, which has been proposed as a biomarker for the 
activity of this system. In general, direct measurement of 
its activity in the oral cavity has allowed its partnership 
with states of pain, stress and disease. As noted above, the 
presence in the saliva of endogenous substances in human 
serum allows saliva be potentially used to diagnose some 
diseases like oral cancer and breast cancer, periodontal di-
sease, Sjögren’s syndrome, among others (65).
The great variability concentration of salivary proteins 
has been used to characterize the state of disease of some 
individuals and is known as biomarkers. According to 
the National Institute of Health in the United States, this 
term is given to a quantitatively measurable biological 
parameter that serves as an indicator of the health and 
physiological assessments related to pathogenic proces-
ses, environmental exposure and the diagnosis of disea-
se or response to drug therapy or therapeutic interven-
tion (66).
Currently, the third molar surgery is the most common 
surgical technique performed in the oral cavity. This of-
ten triggers an inflammatory process which is charac-
terized by symptoms as pain of the operated area, soft 
tissue swelling with subsequent facial deformity, and 
sometimes a degree of lockjaw associated. Normally, 
postoperative requires an average of seven days of labor 
inactivity primarily associated with the inflammation 
that occurs. Therefore, trying to minimize any secondary 
symptoms after oral surgery without interfering in the 
physiological process of inflammation following surgi-
cal trauma should be a primary objective. 
These symptoms are terribly uncomfortable for the 
patient, depending on the intensity of multiple factors 
such as the complexity of the surgery, the duration, the 
surgeon’s technique, the existence of iatrogenic, etc. The 
minimization of such manifestations directly affects the 
satisfaction of the treatment, improves the life quality 
of the patient and also reduces the fear to these surgi-
cal interventions. The concepts to control postoperative 
symptoms have changed substantially over the last years 
as it has advanced the understanding of the pathophysio-
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logical basis of pain and inflammation as well as the me-
chanism of action and pharmacodynamics of analgesics 
and anti-inflammatory used in their treatment although 
nowadays there is more emphasis on the importance of 
preventing both pain and inflammation (67,68).
On the one hand, Holland (69) and Puche et al. (70) de-
fend that the degree of postoperative facial swelling is 
unpredictable and it depends on the different response 
of the patient to the surgical trauma. Seymour et al. (71) 
and Meechan and Seymour (72) argue that the severi-
ty of pain varies from patient to patient and it does not 
seem to be related with the degree of impaction and sur-
gical trauma required to remove the tooth. On the other 
hand, Capuzzi et al. (73), who claim that postoperative 
inflammation is predictable because it depends mainly 
on surgical aggression among other factors. 
Due to understand the way of utilize these biomarkers, 
we presents above the most common material and me-
thods used to detect and measure biomarkers in saliva:
- ELISA 
- Bioplex-Luminex
- FC (Flow Citometry)
- BRADFORD
Disease Saliva Biomarker Reference
   
Cancer 
Epithelial ovarian cancer Night Cortisol Schrepf et al., (37) 2015 
Prostate adenocarcinoma Prostate-specific Antigen (PSA) Shiiki et al., (41) 2011 
Breast carcinoma Proteins of oncogenic expression Streckfus et al., (42) 2008 
Oral squamous cell 
carcinoma    
Protein p53 antibodies IgA and IgG Warnakulasuriya et al., (44) 2000 
Cardiovascular
Acute Myocardial Infarction Matrix Metalloproteinase (MMP)-8 Buduneli et al., (46) 2011 
Acute Myocardial Infarction Creatine Phosphokinase Mirzaii-Dizgah et al., (47) 2011 
Acute Myocardial Infarction Troponin I Mirzaii-Dizgah et al., (48) 2013 
Acute Myocardial Infarction Troponin I, PCR and B-type natriuretic 
peptide. 
Sabatine et al., (52) 2002 
Acute Myocardial Infarction C-reactive protein  Miller et al., (53) 2014 
Metabolic
 Type-2 Diabetes 65 Proteins Rao et al., (32) 2009 
Stress 
Inflammation IL-1-beta Mahmood and Ibrahim, (54) 2013 
Inflammation IL-1b,  IL-6 and TNF-alpha Usui et al., (55) 2012 
Inflammation IL-2, IL-4 and TNF-alpha Filaire  et al., (56) 2010 
Immunity variations IgA Tsujita  et al., ( 57) 1999 

- MRD 
- IFD
- MANCINI
- LORRY
- MS (Mass Spectrometry) 
All the same, the enzyme immunoassay (ELISA), di-
rect immunofluorescence and flow cytometry (CF) are 
the most common methods used in molecular biology 
for prognostic analysis. In this sense, samples can be 
diluted and resuspended or not in the biomedical labo-
ratory after homogenized by vortex. Then, it is possible 
to make an ELISA immunoassay using a 96 wells pla-
te to proceed the samples analyze using a plate lector 
which usually get a standard curve in order to interpola-
te results currently and finally noise balanced using the 
“zero” controls and placebo. Looking to a future point of 
view, salivary fluids seems to be a new efficient diagno-
se and prognostic method in biomedicine and oral disea-
ses at early state. It is also necessary to remark the new 
advanced technique in biomarkers measurement; The 
Detection Chips, which bring the possibility of analyze 
million samples simultaneously and more analytes per 
sample (Table 1).
Table 1: Table of the principal diseases salivary biomarkers.
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Conclusions
• IgA and Cytokines like IL’s and TNF-α & IFN-γ seem 
to be the most used biomarkers used in diagnostic and 
prognostic of oral diseases like Periodontitis and caries 
risk through immunoassays. 
• Α-amylase and Total proteins are also two biomarkers 
commonly utilized in prognostic of oral diseases by 
ELISA or IFD analysis.
• Provide objective data relating to changes sequentially 
in the studied concentration of three components of sali-
va: total protein, immunoglobulin A and alpha-amylase 
in response to oral surgery, improving the understanding 
of the pathophysiology of saliva after surgery in the oral 
cavity.
• Provide criteria for establishing clinical protocols for 
the treatment of postoperative inflammation in patients 
undergoing oral surgery, taking into account the changes 
detected in the concentration of salivary biomarkers stu-
died, thereby contributing to improved quality assistan-
ce practiced in the most prevalent oral cavity surgery.
References
1. Demetriou N, Drikos G, Bambionitakis A. Relation between 
gingival fluid and mixed and parotid salivary IgA. J Periodontol. 
1978;49:64-6.
2. Malon RS, Sadir S, Balakrishnan M, Córcoles EP. Saliva-based bio-
sensors: noninvasive monitoring tool for clinical diagnostics. Biomed 
Res Int. 2014;2014:962903.
3. Lamby CP, Gomez OL, Jaramillo L. Salivary a -Amylase : Relation 
with Dental Caries and Health in General. Univ Odontol. 2013;32:93-
101.  
4. Sadi H, Finkelman M, Rosenberg M. Salivary cortisol, salivary 
alpha amylase, and the dental anxiety scale. Anesth Prog. 2013;60:46-
53.
5. Spielmann N, Wong DT. Saliva: Diagnostics and therapeutic pers-
pectives. Oral Dis. 2011;17:345-54.
6. Castro CE, Koss MA, López ME. Biochemical markers of the perio-
dontal ligament. Med Oral. 2003;8:322-8.
7. Miller CS, King CP, Langub MC, Kryscio RJ, Thomas MV. Salivary 
biomarkers of existing periodontal disease: a cross-sectional study. J 
Am Dent Assoc. 2006;137:322-9.
8. Salvi GE, Franco LM, Braun TM, Lee A, Rutger Persson G, Lang 
NP, Giannobile WV. Pro-inflammatory biomarkers during experimen-
tal gingivitis in patients with type 1 diabetes mellitus: A proof-of-con-
cept study. J Clin Periodontol. 2010;37:9-16.
9. Tsai CC, Ku CH, Ho YP, Ho KY, Wu YM, Hung CC. Changes in 
gingival crevicular fluid interleukin-4 and interferon-gamma in pa-
tients with chronic periodontitis before and after periodontal initial 
therapy. Kaohsiung J Med Sci. 2007;23:1-7.
10. Garrido Flores M, Ordenes Vitali T, Segú Cabrera C, Baeza Paredes M, 
García-Sesnich J, Hernandez Rios M. Asociación entre niveles de TNF-
alpha en fluido crevicular gingival de dientes con periodontitis apical asin-
tomática. Rev Clín Periodoncia Implantol Rehabil Oral. 2011;4:130-3. 
11. Dutzan N, Vernal R, Hernandez M, Dezerega A, Rivera O, Silva 
N, et al. Levels of interferon-gamma and transcription factor T-bet in 
progressive periodontal lesions in patients with chronic periodontitis. 
J Periodontol. 2009;80:290-6.
12. Arroyo-Morales M, Olea N, Ruíz C, del Castilo J de D, Martinez 
M, Lorenzo C, et al. Massage after exercise--responses of immunolo-
gic and endocrine markers: a randomized single-blind placebo-contro-
lled study. J Strength Cond Res. 2009;23:638-44.
13. Ben-Aryeh H, Naon H, Szargel R, Horowitz G, Gutman D. The 
concentration of salivary IgA in whole and parotid saliva and the effect 
of stimulation. Int J Oral Maxillofac Surg; 1986;15:81-4.
14. Favre L, Spertini F, Corthésy B. Secretory IgA possesses intrinsic 
modulatory properties stimulating mucosal and systemic immune res-
ponses. J Immunol. 2005;175:2793-800.
15. Gross A, Setterstrom JA, D’Alessandro SM, Van Swol RL. Immu-
noglobulins in periodontal tissues. I. Concentrations of immunoglobu-
lins in normal and inflamed gingiva. J Periodontol. 1979;50:581-5.
16. Güven O, De Visscher JG. Salivary IgA in periodontal disease. J 
Periodontol. 1982;53:334-5.
17. Kugler J, Hess M, Haake D. Secretion of salivary immunoglobulin 
A in relation to age, saliva flow, mood states, secretion of albumin, 
cortisol, and catecholamines in saliva. J Clin Immunol. 1992;12:45-9.
18. Baik JE, Hong SW, Choi S, Jeon JH, Park OJ, Cho K, Seo DG, 
Kum KY, Yun CH, Han SH. Alpha-amylase is a human salivary pro-
tein with affinity to lipopolysaccharide of Aggregatibacter actinomy-
cetemcomitans. Mol Oral Microbiol. 2013;28:142-53.
19. Fábián TK, Hermann P, Beck A, Fejérdy P, Fabián G. Salivary 
defense proteins: Their network and role in innate and acquired oral 
immunity. Int J Mol Sci. 2012;13:4295-320.
20. Filaire E, Dreux B, Massart A, Nourrit B, Rama LM, Teixeira A. 
Salivary alpha-amylase, cortisol and chromogranin A responses to a 
lecture: Impact of sex. Eur J Appl Physiol. 2009;106:71-7.
21. Henderson AT, Fisher JF, Blair J, Shea C, Li TS, Bridges KG. 
Effects of rib raising on the autonomic nervous system: a pilot study 
using noninvasive biomarkers. J Am Osteopath Assoc. 2010;110:324-
30.
22. Scannapieco F, Torres G, Levine MJ. Salivary alpha-amylase: role 
in dental plaque and caries formation. Crit Rev Oral Biol Med. 1993; 
4:301-7.
23. Pavitra Vibhakar A, Sangeeta Patankar R, Monica Yadav R, Pa-
rag Vibbhakar A. Salivary Total Protein Levels and their correlation to 
Dental Caries. Int J Oral Maxillofac Pathol. 2013;4:13-6. 
24. Nagler R, Lischinsky S, Diamond E, Drigues N, Klein I, Reznick 
AZ. Effect of cigarette smoke on salivary proteins and enzyme activi-
ties. Arch Biochem Biophys. 2000;379:229-36.
25. Rai B, Kharb S, Jain R, Anand SC. Biomarkers of periodontitis in 
oral fluids. J Oral Sci. 2008;50:53-6.
26. Liu J, Duan Y. Saliva: a potential media for disease diagnostics and 
monitoring. Oral Oncol. 2012;48:569-77.
27. Spielmann N, Wong DT. Saliva: diagnostics and therapeutic pers-
pectives. Oral Dis. 2011;17:345-54.
28. Torres-Lagares D, Recio-Lora C, Castillo-Dali G, Ruiz-de-Leon-
Hernandez G, Hita-Iglesias P, Serrera-Figallo MA, et al. Influence of 
state anxiety and trate anxiety in postoperative in oral surgery. Med 
Oral Patol Oral y Cir Bucal. 2014;19:e403–8.
29. Trueba AF, Mizrachi D, Auchus RJ, Vogel PD, Ritz T. Effects of 
psychosocial stress on the pattern of salivary protein release. Physiol 
Behav. 2012;105:841-9.
30. Boyle JO, Mao L, Brennan JA, Koch WM, Eisele DW, Saunders 
JR, Sidransky D. Gene mutations in saliva as molecular markers for 
head and neck squamous cell carcinomas. Amer J Surg. 1994;168:429-
32.
31. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, 
Wong DT. Salivary transcriptomic biomarkers for detection of resecta-
ble pancreatic cancer. Gastroenterology 2010;138:949-57.
32. Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E, Ro-
berts CT, Nagalia SR. Proteomic identification of salivary biomarkers 
of type-2 diabetes. J Proteome Res 2009;8:239-45.
33. Malamud D. Oral diagnostic testing for detecting human immuno-
deficiency virus-1 antibodies: a technology whose time has come. Am 
J Med. 1997;102:9-14.
34. Kountoruras J. Detecting Helicobater pylori. Diagnostic tests for 
Helicobacter pylori. Gut. 1998;42:900-1.
35. Nicholas BL, Skipp P, Barton S, Singh D, Bagmane D, Mould R, 
et al. Identification of lipocalin and apolipoprotein A1 as biomarkers 
of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 
2010; 181:1049-60.
36. Zheng H, Li R, Zhang J, Zhou S, Ma Q, Zhou Y, et al. Salivary bio-
markers indicate obstructive sleep apnea patients with cardiovascular 
diseases. Sci Rep. 2014;4:7046.
J Clin Exp Dent. 2017;9(5):e716-22.                                                                                                                                                                       Salivary biomarkers and inflammation
e722
37. Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, 
Dahmoush L, et al. Diurnal cortisol and survival in epithelial ovarian 
cancer. Psychoneuroendocrinology. 2015;53:256-67.
38. Chang YT, Wu CC, Shyr YM, Chen TC, Hwang TL, Yeh TS, et al. 
Secretome-based identification of ULBP2 as a novel serum marker for 
pancreatic cancer detection. PLoS One. 2011;6:e20029.
39. Vocka M, Langer D, Petrtyl J, Vockova P, Hanus T, Kalousova 
M, et al. Trefoil factor family (TFF) proteins as potential serum bio-
markers in patients with metastatic colorectal cancer. Neoplasma. 
2015;62:470-7.
40. Stiekema A, Boldingh QJ, Korse CM, van der Noort V, Boot H, 
van Driel WJ, et al. Serum human epididymal protein 4 (HE4) as 
biomarker for the differentiation between epithelial ovarian cancer 
and ovarian metastases of gastrointestinal origin. Gynecol Oncol. 
2015;136:562-6.
41. Shiiki N, Tokuyama S, Sato C, Kondo Y, Saruta J, Mori Y, et al. 
Biomarkers. Association between saliva PSA and serum PSA in condi-
tions with prostate adenocarcinoma. Biomarkers. 2011;16:498-503.
42. Streckfus CF, Mayorga-Wark O, Arreola D, Edwards C, Bigler L, 
Dubinsky WP. Breast cancer related proteins are present in saliva and 
are modulated secondary to ductal carcinoma in situ of the breast. Can-
cer Invest. 2008;26:159-67.
43. Turk MJ, Wolchok JD, Guevara-Patino JA, Goldberg SM, 
Houghton AN. Multiple pathways to tumor immunity and concomitant 
autoimmunity. Immunol Rev. 2002;188:122-35.
44. Warnakulasuriya S, Soussi T, Maher R, Johnson N, Tavassoli M. 
Expression of p53 in oral squamous cell carcinoma is associated with 
the presence of IgG and IgA p53 autoantibodies in sera and saliva of 
the patients. J Pathol. 2000;192:52-7.
45. Soussi T. P53 Antibodies in the sera of patients with various types 
of cancer: a review. Cancer Res. 2000;60:1777-88.
46. Buduneli E, Mantyla P, Emingil G, Tervahartiala T, Pussinen P, 
Barış N, Akıllı A, Atilla G, Sorsa T. Acute myocardial infarction is 
reflected in salivary matrix metalloproteinase-8 activation level. J Pe-
riodontol. 2011;82:716-25.
47. Mirzaii-Dizgah I, Jafari-Sabet M. Unstimulated whole saliva 
creatine phosphokinase in acute myocardial infarction. Oral Dis. 
2011;17:597-600.
48. Mirzaii-Dizgah I, Riahi E. Salivary troponin I as an indicator of 
myocardial infarction. Indian J Med Res. 2013;138:861-5.
49. Diercks DB, Kirk JD, Lindsell CJ, Pollack CV Jr, Hoekstra JW, 
Gibler WB, et al. Door-to-ECG time in patients with chest pain pre-
senting to the ED. Am J Emerg Med. 2006;24:1-7.
50. Xiao H, Wong DT. Proteomics and its applications for biomarker 
discovery in human saliva. Bioinformation 2011;5:294-6.
51. Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, Loo JAet 
al. Large-scale identification of proteins in human salivary proteome 
by liquid chromatography/ mass spectrometry and two-dimensional 
gel electrophoresis-mass spectrometry. Proteomics. 2005;5:1714-28.
52. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy 
SA, Rifai N, et al. Multimarker approach to risk stratification in non-
ST elevation acute coronary syndromes: simultaneous assessment of 
troponin I, C-reactive protein, and B-type natriuretic peptide. Circula-
tion. 2002;105:1760-3.
53. Miller CS, Foley JD 3rd, Floriano PN, Christodoulides N, Ebersole 
JL, Campbell CL, et al. Utility of salivary biomarkers for demonstra-
ting acute myocardial infarction. J Dent Res. 2014;93:72S-79S.
54. Mahmood AA, Ibrahim LM. Effects of the examination stress on 
periodontal health status and salivary IL-1b among Iraqi dental stu-
dents. J Baghdad Coll Dent. 2013;24:72-8. 
55. Usui T, Yoshikawa T, Ueda SY, Katsura Y, Orita K, Fujimoto S. 
Effects of acute prolonged strenuous exercise on the salivary stress 
markers and inflammatory cytokines. Jpn J Phys Fitness Sports Med. 
2011;60:295-304. 
56. Filaire E, Larue J, Portier H, Abed A, Graziella PD, Teixeira A, et al. 
Lecturing to 200 students and its effects on cytokine concentration and 
salivary markers of adrenal activation. Stress Health. 2011;27:e25-35. 
57. Tsujita S, Morimoto K. Secretory IgA in saliva can be a useful 
stress marker. Environ Health Prev Med. 1999;4:1-8.
58. Brandtzaeg P. Human secretory immunoglobulins. 3. Immuno-
chemical and physicochemical studies of secretory IgA and free se-
cretory piece. Acta Pathol Microbiol Scand B Microbiol Immunol. 
1971;79:165-88.
59. Brandtzaeg P. Secretory immunity with special reference to the 
oral cavity. J Oral Microbiol. 2013;5. Epub 2013 Mar 11.
60. Demetriou N, Drikos G, Bambionitakis A. Relation between 
Gingival Fluid and Mixed and Parotid Salivary IgA. J Periodontol. 
1978;49:64-6.
61. Ben-Aryeh H, Naon H, Szargel R, Horowitz G, Gutman D. The 
concentration of salivary IgA in whole and parotid saliva and the effect 
of stimulation. Int J Oral Maxillofac Surg. 1986;1:81-4.
62. Brandtzaeg P. Human Secretory Inmunoglobulins-VII of Parotid 
IgA and Other Secretory Proteins in Relation to the Rate of Flow and 
Duration of Secretory Stimulus. Arch Oral Biol. 1971;16:1295-310.
63. Fábián TK, Hermann P, Beck A, Fejérdy P, Fábián G. Salivary 
defense proteins: their network and role in innate and acquired oral 
immunity. Int J Mol Sci. 2012;13:4295-320.
64. Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, et al. Adaptive 
immune cells temper initial innate responses. Nat Med. 2007;13:1248-
52.
65. Nater UM, Rohleder N. Salivary alpha-amylase as a non-invasive 
biomarker for the sympathetic nervous system: current state of re-
search. Psychoneuroendocrinology. 2009;34:486-96.
66. de Santana-Santos T, de Souza-Santos AA, Martins- Filho PR, da 
Silva LC, de Oliveira E, Silva ED, et al. Prediction of postoperative 
facial swelling, pain and trismus following third molar surgery based 
on preoperative variables. Med Oral Patol Oral Cir Bucal. 2013;18:65-
70.
67. Laskin DM, Abubaker AO, Strauss RA. Accuracy of predic-
ting the duration of a surgical operation. J Oral Maxillofac Surg. 
2013;71:446-7.
68. Bello S, Adeyemo W, Bamgbose BO, Obi EV, Adeyinka A. Effect 
of age, impaction types and operative time on inflammatory tissue reac-
tions following lower third molar surgery. Head Face Med. 2011;7:8.
69. Holland CS. The influence of methylprednisolone on postopera-
tive swelling following oral surgery. Br J Oral and Maxillofac Surg. 
1987;25:293-9.
70. Puche F, Martínez Gonzalez JM, Blanco L, Gómez Font R, Do-
nado M. Estudio de los efectos del diclofenaco sódico en el control 
de la inflamación y trismo postoperatorio del tercer molar inferior. Av 
Odontoestomatol. 1995;11:225-33.
71. Seymour R, Meechan JG, Blair GS. An investigation into post-
operative pain after third molar surgery under local analgesia. Br J 
Oral Maxillofac Surg. 1985;23:410-8.
72. Meechan R, Seymour A. The use of third molar surgery in clinical 
pharmacology. Br J Oral Maxillofacial Surg. 1993;31:360-5.
73. Capuzzi P, Montebugnoli L, Vaccaro MA. Extraction of impac-
ted third molars. A longitudinal prospective study on factors that 
affect postoperative recovery. Oral Surg Oral Med Oral Pathol. 
1994;77:341-3. 
Conflict of Interest
The authors have declared that no conflict of interest exist.
